SG11201701398SA - Resetting pluripotent stem cells - Google Patents

Resetting pluripotent stem cells

Info

Publication number
SG11201701398SA
SG11201701398SA SG11201701398SA SG11201701398SA SG11201701398SA SG 11201701398S A SG11201701398S A SG 11201701398SA SG 11201701398S A SG11201701398S A SG 11201701398SA SG 11201701398S A SG11201701398S A SG 11201701398SA SG 11201701398S A SG11201701398S A SG 11201701398SA
Authority
SG
Singapore
Prior art keywords
resetting
stem cells
pluripotent stem
pluripotent
cells
Prior art date
Application number
SG11201701398SA
Inventor
Austin Smith
Ge Guo
Yasuhiro Takashima
Original Assignee
Cambridge Entpr Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54011046&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201701398S(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB201414992A external-priority patent/GB201414992D0/en
Priority claimed from GB201415368A external-priority patent/GB201415368D0/en
Application filed by Cambridge Entpr Ltd filed Critical Cambridge Entpr Ltd
Publication of SG11201701398SA publication Critical patent/SG11201701398SA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/99—Serum-free medium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/065—Modulators of histone acetylation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/119—Other fibroblast growth factors, e.g. FGF-4, FGF-8, FGF-10
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/235—Leukemia inhibitory factor [LIF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/604—Klf-4
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/605—Nanog
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/72—Transferases (EC 2.)
    • C12N2501/724—Glycosyltransferases (EC 2.4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/72—Transferases (EC 2.)
    • C12N2501/727—Kinases (EC 2.7.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/73—Hydrolases (EC 3.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/90—Polysaccharides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/52—Fibronectin; Laminin
SG11201701398SA 2014-08-22 2015-08-21 Resetting pluripotent stem cells SG11201701398SA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB201414992A GB201414992D0 (en) 2014-08-22 2014-08-22 Resetting human pluripotent stem cells
GB201415368A GB201415368D0 (en) 2014-08-29 2014-08-29 Resetting pluripotent stem cells
PCT/GB2015/052431 WO2016027099A2 (en) 2014-08-22 2015-08-21 Resetting pluripotent stem cells

Publications (1)

Publication Number Publication Date
SG11201701398SA true SG11201701398SA (en) 2017-03-30

Family

ID=54011046

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201701398SA SG11201701398SA (en) 2014-08-22 2015-08-21 Resetting pluripotent stem cells

Country Status (6)

Country Link
US (1) US10894948B2 (en)
EP (1) EP3183336B1 (en)
CN (1) CN107075472A (en)
IL (1) IL250689B (en)
SG (1) SG11201701398SA (en)
WO (1) WO2016027099A2 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106661548B (en) 2014-05-28 2020-12-11 儿童医院医疗中心 Methods and systems for converting precursor cells to stomach tissue via directed differentiation
WO2016055519A1 (en) * 2014-10-07 2016-04-14 Max-Delbrück-Centrum für Molekulare Medizin Endogenous retrovirus transcription as a marker for primate naïve pluripotent stem cells
EP3207123A1 (en) 2014-10-17 2017-08-23 Children's Hospital Center D/b/a Cincinnati Children's Hospital Medical Center In vivo model of human small intestine using pluripotent stem cells and methods of making and using same
JP6963882B2 (en) 2016-05-05 2021-11-10 チルドレンズ ホスピタル メディカル センター Methods for the in vitro production of fundic tissue and compositions associated with such methods.
WO2018085419A1 (en) * 2016-11-01 2018-05-11 Jian Feng Method of producing naive pluripotent stem cells
KR20230110839A (en) 2016-12-05 2023-07-25 칠드런즈 호스피탈 메디칼 센터 Colonic organoids and methods of making and using same
WO2019151386A1 (en) 2018-01-31 2019-08-08 富士フイルム株式会社 Method for producing cells
CN110423721B (en) * 2018-05-01 2024-02-27 云南济慈再生医学研究院有限公司 Preparation method and application of younger repair type fibroblast
CN110423719B (en) * 2018-05-01 2024-02-27 云南济慈再生医学研究院有限公司 Technology for regulating Jak-Stat pathway to differentiate, dedifferentiate and rejuvenate cells and application thereof
IT201800006076A1 (en) 2018-06-06 2019-12-06 niPSCs from somatic cells
US20220010283A1 (en) * 2018-10-31 2022-01-13 Kyoto University Method for producing pluripotent stem cell having released differentiation resistance to mesendoderm
US20220145264A1 (en) * 2019-04-05 2022-05-12 The University Of Hong Kong Culture medium for mammalian expanded potential stem cells, composition, and methods thereof
JP2022534395A (en) * 2019-05-31 2022-07-29 チルドレンズ ホスピタル メディカル センター Compositions and methods for cell reprogramming
WO2021015228A1 (en) * 2019-07-25 2021-01-28 富士フイルム株式会社 Method for producing specific differentiated cells
WO2021020267A1 (en) * 2019-07-26 2021-02-04 富士フイルム株式会社 Medium for enhancing proliferation ability of naive type pluripotent stem cells and method for producing pluripotent stem cells
AU2021350981A1 (en) * 2020-09-24 2023-06-08 Beijing Institute For Stem Cell And Regenerative Medicine Activated pluripotent stem cell, and preparation method therefor and use thereof
EP4269571A1 (en) * 2020-12-25 2023-11-01 Kyoto University Method for producing naive human ips cells from somatic cells
EP4029932A1 (en) 2021-01-13 2022-07-20 IMBA-Institut für Molekulare Biotechnologie GmbH Blastocyst-like cell aggregate and methods
EP4277978A1 (en) 2021-01-13 2023-11-22 IMBA-Institut für Molekulare Biotechnologie GmbH Blastocyst-like cell aggregate and methods
US20240093154A1 (en) * 2021-02-01 2024-03-21 Cedars-Sinai Medical Center Generation of functional human ipsc-derived pancreatic islets in co-culture with isogenic ipsc-derived vascular endothelial cells
WO2023076577A2 (en) * 2021-10-28 2023-05-04 Memorial Sloan-Kettering Cancer Center Methods for modulating cell pluripotency and self-renewal property
WO2023173370A1 (en) * 2022-03-17 2023-09-21 Guangzhou Institutes Of Biomedicine And Health, Chinese Academy Of Sciences Media and methods for producing human cells and tissues from teratoma, organoids and embryoid bodies
CN116970552A (en) * 2022-04-22 2023-10-31 广州国家实验室 Induction method of mammal early embryo-like cells and application thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0606392D0 (en) * 2006-03-30 2006-05-10 Univ Court Of The Univeresity Culture medium containing kinase inhibitors, and uses thereof
JP5680850B2 (en) 2006-03-30 2015-03-04 ザ・ユニバーシティ・コート・オブ・ザ・ユニバーシティ・オブ・エディンバラＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｃｏｕｒｔ ｏｆ ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ ｏｆ Ｅｄｉｎｂｕｒｇｈ Culture medium containing kinase inhibitor and use thereof
JP2008099662A (en) * 2006-09-22 2008-05-01 Institute Of Physical & Chemical Research Method for culturing stem cell
KR101723144B1 (en) 2008-12-17 2017-04-06 더 스크립스 리서치 인스티튜트 Generation and maintenance of stem cells
US20110088107A1 (en) * 2009-04-24 2011-04-14 Yaqub Hanna Compositions and methods for deriving or culturing pluripotent cells
US8193235B2 (en) * 2009-06-12 2012-06-05 University Of Kansas Compositions and methods for establishing and maintaining stem cells in an undifferentiated state
WO2011084747A2 (en) 2009-12-21 2011-07-14 The Johns Hopkins University Compositions and methods for somatic tissue induced pluripotent stem cells having an endoderm origin
WO2011130624A2 (en) * 2010-04-16 2011-10-20 Immune Disease Institute, Inc. Sustained polypeptide expression from synthetic, modified rnas and uses thereof
US9732319B2 (en) * 2010-12-22 2017-08-15 Fate Therapeutics, Inc. Cell culture platform for single cell sorting and enhanced reprogramming of iPSCs
DE102012102532A1 (en) 2012-03-23 2013-09-26 Eberhard-Karls-Universität Tübingen Universitätsklinikum New MSC surface markers
CN105531365A (en) * 2013-04-23 2016-04-27 耶达研究及发展有限公司 Isolated naive pluripotent stem cells and methods of generating same
WO2016016894A1 (en) 2014-07-30 2016-02-04 Yeda Research And Development Co. Ltd. Media for culturing pluripotent stem cells
WO2016055519A1 (en) 2014-10-07 2016-04-14 Max-Delbrück-Centrum für Molekulare Medizin Endogenous retrovirus transcription as a marker for primate naïve pluripotent stem cells
WO2016079146A1 (en) 2014-11-17 2016-05-26 Genome Research Limited In vitro production of expanded potential stem cells
JP6719449B2 (en) 2015-03-18 2020-07-08 小野薬品工業株式会社 Method for producing naive pluripotent stem cells

Also Published As

Publication number Publication date
IL250689A0 (en) 2017-04-30
EP3183336B1 (en) 2020-11-25
CN107075472A (en) 2017-08-18
US20180112187A1 (en) 2018-04-26
EP3183336A2 (en) 2017-06-28
US10894948B2 (en) 2021-01-19
WO2016027099A2 (en) 2016-02-25
IL250689B (en) 2020-11-30
WO2016027099A3 (en) 2016-04-14

Similar Documents

Publication Publication Date Title
IL250689A0 (en) Resetting pluripotent stem cells
IL274903A (en) Cell
IL267616A (en) Immunoengineered pluripotent cells
SG11201801549VA (en) Pluripotent stem cell production system
IL250132A0 (en) Method for inducing t cells for immunocytotheraphy from pluripotent stem cells
HK1226150A1 (en) Timepiece
AU359725S (en) Watchcase
SG11201607925SA (en) Improved stem cell composition
LT3157504T (en) Stem cell stimulating compositions
GB2535007B (en) Prosthesis
EP3134096A4 (en) Methods of enhancing stem cell engraftment
IL252570A0 (en) Small cell backhaul
PL3149792T3 (en) Lithium-sulphur cell
SG11201703600YA (en) Method of distinguishing mesenchymal stem cells
SG10201403640XA (en) Stem cells
GB201415368D0 (en) Resetting pluripotent stem cells
HK1252554A1 (en) Pluripotent stem cell production system
GB201414992D0 (en) Resetting human pluripotent stem cells
AU362519S (en) Watch
AU362521S (en) Watch
AU362520S (en) Watch
AU362518S (en) Watch
GB201416750D0 (en) Cell preparation
SG10201800796XA (en) Method of distinguishing mesenchymal stem cells
GB201410934D0 (en) T cell